Found 9 matching trials
Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4 PHASE4 Subjects will be recruited and divided into 3 groups:
1. Experimental Grou...
Show More Location
Liucheng Community Health Services Center
Learn More & Join Trial
Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4 PHASE4 Subjects will be recruited and divided into 3 groups:
Experimental Group (...
Show More Location
Guangdong Center for Disease Control and Prevention
Learn More & Join Trial
Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population PHASE4 Evaluation of immunogenicity and safety of inactivated COVID-19 vaccine (BB...
Show More Location
Xiangya Hospital Central South University
Learn More & Join Trial
A Study of Booster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza Vaccine and Pneumococcal Polysaccharide Vaccine PHASE4 This study is a single center , randomized ,controlled and open-label phase...
Show More Location
Beijing Centers for Diseases Control and Prevention
Learn More & Join Trial
Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older PHASE2 Infections due to influenza and pneumococcus can be very serious and cause ...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Study Evaluating 13 Valent Pneumococcal Conjugate Vaccine With Trivalent Inactivated Influenza Vaccine PHASE3 This study is to evaluate the safety, tolerability and immune response when...
Show More Location
Clinical Research Advantage, Inc.
Learn More & Join Trial
Concomitant Administration of 13-valent Pneumococcal Conjugate Vaccine (13vPnC) With Influenza Vaccine in 23-valent Pneumococcal Polysaccharide (23vPS) Pre-vaccinated Adults. PHASE4 The purpose of this study is to evaluate the immunogenicity and safety of 1...
Show More Location
Achieve Clinical Research, LLC
Learn More & Join Trial
Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4 PHASE4 Subjects will be recruited and divided into 3 groups:
Experimental Group (...
Show More Location
Sichuan Center for Disease Control and Prevention
Learn More & Join Trial
Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-Ξ² or No Disease Modifying Therapy PHASE3 This study is designed to provide data on the immune response and safety of...
Show More Location
Stanford University
Learn More & Join Trial